These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1722253)

  • 1. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
    Hanson GR; Singh N; Bush L; Gibb JW
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
    Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
    Westwood SC; Hanson GR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK; Schmidt CJ; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1984 May; 229(2):487-92. PubMed ID: 6201607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methamphetamine on neurotensin concentrations in rat brain regions.
    Letter AA; Merchant K; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1987 May; 241(2):443-7. PubMed ID: 3572804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of neurotensin to methamphetamine self-administration.
    Frankel PS; Hoonakker AJ; Hanson GR
    Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of responses by neuropeptide systems in rat to the psychotropic drugs, methamphetamine, cocaine and PCP.
    Hanson GR; Midgley LP; Bush LG; Johnson M; Gibb JW
    NIDA Res Monogr; 1989; 95():348. PubMed ID: 2484267
    [No Abstract]   [Full Text] [Related]  

  • 16. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
    Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
    Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
    Hanson GR; Merchant KM; Letter AA; Bush L; Gibb JW
    Eur J Pharmacol; 1988 Oct; 155(1-2):11-8. PubMed ID: 2907484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.